299+ Free VT MPJE Practice Questions

Pass your Vermont Multistate Pharmacy Jurisprudence Examination exam on the first try — instant access, no signup required.

✓ No registration✓ No credit card✓ No hidden fees✓ Start practicing immediately

Not publicly reported Pass Rate

299+ Questions

100% Free

1 / 299

Question 1

Score: 0/0

Under the Controlled Substances Act (CSA), which DEA schedule includes drugs with the highest potential for abuse and no currently accepted medical use?

Schedule I

Schedule II

Schedule III

Schedule IV

to track

Same family resources

More MPJE Pharmacy Jurisprudence Prep

Continue through related practice pages, study guides, comparisons, and articles from the same exam family.

Practice Pages

NABP MPJE Multistate Pharmacy Jurisprudence Examination Practice199 questions Alabama MPJE Pharmacy Jurisprudence Practice299 questions Alaska MPJE Pharmacy Jurisprudence Practice299 questions Arizona MPJE Pharmacy Jurisprudence Practice299 questions Arkansas MPJE Pharmacy Jurisprudence Practice299 questions Colorado MPJE Pharmacy Jurisprudence Practice299 questions

Free MPJE Practice Test by State 2026: 5,000+ Pharmacy Law Questions18 min read

2026 Statistics

Key Facts: VT MPJE Exam

120

Questions

100 scored + 20 pretest

Passing Score

NABP scaled score

2.5h

Exam Time

Pearson VUE

3:1

Tech Ratio

VT max

30h/2yr

CE Required

VT renewal

$250

Exam Fee

NABP 2026

The VT MPJE covers federal pharmacy law (DEA, FDA, CSA, HIPAA) and Vermont-specific regulations including VPMS mandatory checks, naloxone standing order, collaborative prescribing authority, expanded pharmacist scope, 30h/2yr CE, and 3:1 technician ratio.

Sample VT MPJE Practice Questions

Try these sample questions to test your VT MPJE exam readiness. Each question includes a detailed explanation. Start the interactive quiz above for the full 299+ question experience with AI tutoring.

1Under the Controlled Substances Act (CSA), which DEA schedule includes drugs with the highest potential for abuse and no currently accepted medical use?

A.Schedule I

B.Schedule II

C.Schedule III

D.Schedule IV

Explanation: Schedule I substances have a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision. Examples include heroin, LSD, and MDMA. Pharmacists cannot dispense Schedule I substances under normal practice.

2A DEA Form 222 is required for the transfer of which schedule of controlled substances between registrants?

A.Schedule II only

B.Schedules II and III

C.Schedules III through V

D.All controlled substances

Explanation: DEA Form 222 (or its electronic equivalent under CSOS) is required for the distribution and transfer of Schedule II controlled substances between DEA registrants. Schedules III-V can be transferred using invoices with specific record-keeping requirements.

3Under federal law, what is the maximum number of refills allowed for a Schedule III controlled substance prescription?

A.No refills allowed

B.Up to 3 refills within 6 months

C.Up to 5 refills within 6 months

D.Up to 5 refills within 1 year

Explanation: Federal law allows up to 5 refills for Schedule III-V controlled substance prescriptions within 6 months from the date the prescription was issued. Schedule II prescriptions cannot be refilled. After 6 months or 5 refills, a new prescription is required.

4The Durham-Humphrey Amendment of 1951 established which key distinction in drug classification?

A.Generic vs. brand-name drugs

B.Prescription (legend) vs. over-the-counter drugs

C.Controlled vs. non-controlled substances

D.Biological vs. chemical drugs

Explanation: The Durham-Humphrey Amendment to the Federal Food, Drug, and Cosmetic Act (FDCA) established the distinction between prescription (legend) drugs and over-the-counter (OTC) drugs. It required that certain drugs be dispensed only with a valid prescription and bear the legend 'Caution: Federal law prohibits dispensing without prescription.'

5Under the Poison Prevention Packaging Act (PPPA), which of the following medications is EXEMPT from child-resistant packaging requirements?

A.Acetaminophen tablets

B.Sublingual nitroglycerin tablets

C.Amoxicillin suspension

D.Hydrocodone/acetaminophen tablets

Explanation: Sublingual nitroglycerin tablets are exempt from child-resistant packaging under the PPPA because they require immediate access during cardiac emergencies. Other exemptions include oral contraceptives in manufacturer dispensing packages, certain hormone replacement therapy, and isosorbide dinitrate sublingual tablets.

6What is the primary purpose of the FDA's Risk Evaluation and Mitigation Strategies (REMS) program?

A.To reduce drug manufacturing costs

B.To ensure the benefits of a drug outweigh its risks

C.To speed up the drug approval process

D.To establish drug pricing guidelines

Explanation: REMS are drug safety programs required by the FDA for certain medications with serious safety concerns. They help ensure the benefits of a medication outweigh its risks. REMS may include medication guides, communication plans, and Elements to Assure Safe Use (ETASU) such as prescriber certification and patient registries.

7Under the Combat Methamphetamine Epidemic Act (CMEA), what is the maximum amount of pseudoephedrine a customer can purchase in a 30-day period?

A.3.6 grams

B.7.5 grams

C.9 grams

D.15 grams

Explanation: The CMEA limits pseudoephedrine purchases to 3.6 grams per day and 9 grams per 30-day period for retail transactions. Mail-order purchases are limited to 7.5 grams per 30-day period. Retailers must keep a logbook of all pseudoephedrine sales and products must be kept behind the counter.

8A pharmacist receives a prescription for a Schedule II controlled substance dated 45 days ago. Under federal law, this prescription:

A.Must be filled within 30 days

B.May be filled as there is no federal time limit

C.Cannot be filled because it has expired

D.May only be partially filled

Explanation: Federal law does not impose a specific time limit on filling Schedule II prescriptions. However, many states, including Vermont, may impose their own time limits. The pharmacist must use professional judgment to determine whether the prescription is still valid based on the patient's needs and state law requirements.

9Under the Health Insurance Portability and Accountability Act (HIPAA), which of the following is NOT considered protected health information (PHI)?

A.A patient's prescription history

B.A patient's date of birth

C.De-identified aggregate prescription data

D.A patient's home address

Explanation: De-identified data is not considered PHI under HIPAA. PHI includes individually identifiable health information such as names, dates, addresses, Social Security numbers, and medical records. Data that has been properly de-identified according to HIPAA standards (Safe Harbor or Expert Determination method) is not subject to HIPAA restrictions.

10Under the Drug Supply Chain Security Act (DSCSA), what must be included with each transaction of a prescription drug between trading partners?

A.Only the drug name and NDC number

B.Transaction information, transaction history, and transaction statement

C.DEA Form 222 and invoice

D.Certificate of analysis and lot number only

Explanation: The DSCSA requires three types of documentation for each prescription drug transaction: transaction information (drug details, date, entities involved), transaction history (previous ownership chain), and transaction statement (attestation that the trading partner meets DSCSA requirements). This supports drug supply chain integrity and helps prevent counterfeit drugs.

About the VT MPJE Exam

The Vermont MPJE tests knowledge of federal pharmacy law and Vermont-specific pharmacy regulations under 26 V.S.A. Chapter 36. Required alongside the NAPLEX for pharmacist licensure in Vermont.

Questions

120 scored questions

Time Limit

2.5 hours

Passing Score

75 (scaled score)

Exam Fee

$250 (NABP / VT Board of Pharmacy)

VT MPJE Exam Content Outline

22%

Licensure & Personnel

Pharmacist qualifications, intern/technician requirements, license renewal, disciplinary actions

33%

Pharmacist Practice

Prescription requirements, counseling, controlled substance rules, collaborative practice agreements

24%

Dispensing Requirements

Generic substitution, prescription transfers, DUR, labeling, PDMP checking

21%

Pharmacy Operations

Controlled substance records, compounding standards, pharmacy permits, automated dispensing

How to Pass the VT MPJE Exam

What You Need to Know

Passing score: 75 (scaled score)
Exam length: 120 questions
Time limit: 2.5 hours
Exam fee: $250

Keys to Passing

Complete 500+ practice questions
Score 80%+ consistently before scheduling
Focus on highest-weighted sections
Use our AI tutor for tough concepts

VT MPJE Study Tips from Top Performers

1Study 26 V.S.A. Chapter 36 for Vermont-specific pharmacy regulations

2Master DEA controlled substance schedules, forms (222, 106, 41), and corresponding responsibility

3Know Vermont PDMP requirements and mandatory query triggers

4Review Vermont naloxone standing order and collaborative practice agreements

5Understand federal vs. state law conflicts — the more restrictive law prevails

Frequently Asked Questions

What is the VT MPJE passing score?

The Vermont MPJE requires a scaled score of 75. The exam has 120 questions (100 scored, 20 pretest) over 2.5 hours at Pearson VUE.

What Vermont laws are tested?

The VT MPJE covers 26 V.S.A. Chapter 36, Board of Pharmacy rules, PDMP requirements, collaborative practice, and state-specific dispensing/controlled substance regulations.

What is the technician ratio in Vermont?

Vermont allows a 3:1 technician-to-pharmacist ratio. Technicians must be registered/licensed and work under direct pharmacist supervision.

How many CE hours does Vermont require?

Vermont requires 30h/2yr of continuing pharmacy education per renewal period. CE must be ACPE-accredited.